Compounds > 3-aminobenzamide

3-aminobenzamide and veliparib

3-aminobenzamide has been researched along with veliparib in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Chu, Z; Dong, G; He, G; Wang, X; Xu, Y; Zhu, Q1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Hammarström, M; Karlberg, T; Schüler, H; Schütz, P; Svensson, L1
Choi, SK; Galán, M; Kassan, M; Matrougui, K; Partyka, M; Trebak, M1
He, YJ; Liu, RH; Ning, CQ; Yu, NF1
Guo, X; Hong, H; Li, Z; Liu, P; Lu, J; Sun, D; Sun, S; Yang, Z; Ye, J; Zhang, R1

Reviews

1 review(s) available for 3-aminobenzamide and veliparib

ArticleYear
[Research progresses of the PARP inhibitors for the treatment of cancer].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2013, Volume: 48, Issue:5

    Topics: Animals; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; DNA Repair; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Indoles; Melanoma; Mutation; Ovarian Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors

2013

Other Studies

5 other study(ies) available for 3-aminobenzamide and veliparib

ArticleYear
Design, synthesis and biological evaluation of novel imidazo[4,5-c]pyridinecarboxamide derivatives as PARP-1 inhibitors.
    Bioorganic & medicinal chemistry letters, 2013, Apr-01, Volume: 23, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Imidazoles; Mice; Molecular Structure; Neoplasms, Experimental; Niacinamide; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Crystal structure of the catalytic domain of human PARP2 in complex with PARP inhibitor ABT-888.
    Biochemistry, 2010, Feb-16, Volume: 49, Issue:6

    Topics: Animals; Benzamides; Benzimidazoles; Catalytic Domain; Cell Cycle Proteins; Crystallization; Crystallography, X-Ray; Glutamic Acid; Humans; Hydrogen Bonding; Mice; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Structure, Secondary

2010
Poly(ADP-ribose) polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:5

    Topics: Animals; Benzimidazoles; Blood Glucose; Blood Pressure Determination; Blotting, Western; Body Weight; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Down-Regulation; Immunohistochemistry; Indoles; Insulin Resistance; Mice; Mice, Inbred Strains; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polymerase Chain Reaction; Random Allocation; Sensitivity and Specificity

2012
The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.
    Biochimica et biophysica acta, 2016, Volume: 1863, Issue:12

    Topics: Adenoviridae; Animals; Animals, Newborn; Benzamides; Benzimidazoles; Cardiomegaly; Echocardiography; Forkhead Box Protein O3; Genetic Vectors; Isoproterenol; Male; Myocytes, Cardiac; Poly (ADP-Ribose) Polymerase-1; Poly Adenosine Diphosphate Ribose; Primary Cell Culture; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription, Genetic

2016